Real-world data on patients’ adherence to prescribed treatment schedules with carfilzomib and dexamethasone (Kd), or in combination with lenalidomide (KRd) or daratumumab (KdD) in patients with multiple myeloma – Results from the interim analysis 3 of CARO

Knauf, Wolfgang; Uhlig, Jens; Von der Heyde, Eyck; Losem, Christoph ; Ammon, Andreas; Nusch, Arnd; Schlag Rudolf; Schulz, Holger; Behlendorf, Timo; Siebenbach, Hans Ulrich; Serrer, Laura; Woerner, Sandra; Potthoff, Karin; 2024

Download